A B S T R A C T This study has
INTRODUCTION
Plasma contains a family of proteolytic enzyme inhibitors which regulate and modulate, in an incompletely understood manner, the participation of several interrelated enzyme systems in various inflammatory and hemostatic reactions. One of these inhibitor's a2-macroglobulin, may regulate several different proteolytic effector pathways, as it has been shown to inhibit enzymes of the kinin-forming, coagulation, and fibrinolytic systems. These include kallikrein (1, 2), thrombin (3) , and plasmin (4-6) as well as a group of proteases including trypsin, chymotrypsin, elastase, papain, and other enzymes (7) . Recent studies have indicated that plasma a2-macroglobulin is proteolytically cleaved by the enzymes which it inhibits and that the altered inhibitor molecule is incorporated in a protein-protein complex with the inhibited enzyme (8) .
Another plasma protein inhibitor, C1 inactivator,1 inhibits enzymes of the complement, kinin-forming, coagulation, and fibrinolytic systems. These include C! and its subcomponents Cis and Clr (9-13), kallikrein, PF/dil (permeability factor of dilution) (13) (14) (15) (16) , plasmin (13, 17) , Hageman factor (18) and its active fragments (17) , and plasma thromboplastin antecedent (2, 18) . Cl inactivator, however, has been found to be a relatively ineffective inhibitor of trypsin and chymotrypsin (10, 19) . Although the inhibitory spectrum of CI inactivator has been defined, the molecular basis of enzyme inhibition by C! inactivator has remained obscure.
In the present study, we have investigated molecular interactions which occur between Cl inactivator and Cls, plasmin, and trypsin. C1 inactivator was found to interact with each enzyme in a different manner. Incubation with Cls led to rapid formation of a stable bimolecular complex with associated loss of Cis functional activity. Proteolytic degradation of Cl inactivator, as judged by the production of lower molecular weight C1 inactivator products was not detected. Similar complex formation with concomitant functional inactivation occurred on adding plasmin to C! inactivator. In addition, however, plasmin degraded C1 inactivator and produced several characteristic derivatives, at least one of which retained the ability to complex with plasmin and with Cis. Trypsin did not form a complex with C1 inactivator under the analytical conditions used, although it did partially degrade and inactivate the inhibitor. These derivatives, one of which appeared to be structurally similar to that generated by plasmin, were unable to complex with Cls or plasmin. Other studies revealed that the light chain of both Cls and plasmin provided the binding site for Cl inactivator. In addition, complex formation and enzyme inhibition occurred only with native and not denatured C1 inactivator, suggesting a major role for conformational factors in complex formation. These studies thus provide new data on the mechanisms involved in enzyme inhibition and regulation by C1 inactivator.
METHODS
All chemicals2 used were reagent grade and were obtained from the following sources: N-a-acetyl-L-lysine methyl ester HCl and p-nitrophenyl-p'-guanidinobenzoate HCI from Cyclo Chemical, Division Travenol Laboratories, Inc., Los Angeles, Calif.; e-aminocaproic acid from Fluka AG., Basel, Switzerland; Polybrene (hexadimethrine bromide) and urokinase, 200,000 U/vial, from Abbott Laboratories, North Chicago, I The complement terminology used conforms to the recommendations of the World Health Organization Committee on Complement Nomenclature (1968. Bull. W. H. 0. 39: 935-938).
Ill.; soybean trypsin inhibitor (salt free) (SBTI)2 and bovine trypsin (three times crystallized, salt free) from Worthington Biochemical Corp., Freehold, N. J.; dithiothreitol (DTT) and methyl-a-D-mannopyranoside from Calbiochem, San Diego, Calif.; sodium dodecyl sulfate (SDS) from Sigma Chemical Co., St. Louis, Mo.; polyethylene glycol (Carbowax 4000) from Union Carbide Corp., Clifton, N. J.
Human plasma C! inactivator was isolated by a methodology not previously described. All procedures were performed with plastic containers or siliconized glassware and in the presence of inhibitors to minimize activation of plasma proteases (8, 20) . The materials, including resins used for chromatographic separation, were prewashed in buffer containing Polybrene (50 jug/ml). All buffers contained sodium azide, 0.02%, to inhibit bacterial contamination. Plasma (200 ml) was harvested from freshly obtained acid citrate dextrose blood by centrifugation at 2,000 g for 15 min at 40C. After separation, SBTI (275 pg/ml plasma), Polybrene (140 jug/ml plasma), and sodium EDTA (0.02 M final concentration) were added to the plasma. Barium chloride was added (1.0 M to a final concentration of 0.1 M) and mixed with the plasma 10 min at 250C to reduce the concentration of the prothrombin complex. After centrifugation, the adsorbed plasma was diluted with 2 vol of 0.02 M phosphate buffer, pH 7.4, containing 0.1 M NaCl, and polyethylene glycol (50% wt/wt in H20) was added at 250C to a final concentration of 12% (vol/vol). After removal of the precipitate by centrifugation (30 min, 2,000 g), polyethylene glycol was added to a final concentration of 22% at 25'C and the solution adjusted to pH 5.8. The pellet from the 12-22% polyethylene glycol fraction was obtained by centrifugation (60 min, 2,000 g), and was resuspended in buffer (0.05 M Tris-HCl, pH 8.0, containing 0.02 M NaCl, 50;jg/ml SBTI, and 25,ug/ml Polybrene) and the Cl inactivator further purified on a 5.0 X 40-cm DEAE-cellulose column at 40C (DE-52, H. Reeve Angel & Co., Inc., Clifton, N. J.) with a linear sodium chloride gradient at constant pH (starting buffer, 1,500 ml 0.05 M Tris-HCl, pH 8.0, and the limit buffer, 1,500 ml, containing 0.4 M NaCl). Ci inactivator was identified in the second portion of the main protein peak in fractions having a conductivity of 13.5-15.5 mmho/cm (27°C) by using a type CDM 2e conductivity meter with a CDC 104 probe (Radiometer Co., Copenhagen, Denmark) by double diffusion analysis with rabbit anti-Cl inactivator. The fractions containing the peak of C1 inactivator were concentrated by ultrafiltration (Diaflo membrane PM-10, Amicon Corp., Lexington, Mass.), and applied to a 5.0 X 100-cm column of Bio-Gel A-5m, at 40C (Bio-Rad Laboratories, Richmond, Calif.). The fractions containing C1 inhibitor were then pooled, concentrated, and subjected to a preparative electrophoresis in Pevikon (Kema Nord, Stockholm, Sweden) (21) . After elution, the major contaminating protein, albumin, was removed by passing the C1 inactivator preparation through a 20-ml column of concanavalin A-Sepharose (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). The inhibitor was eluted from the affinity resin with 5% methyl-a-D-mannopyranoside in 0.05 M Tris-HCl buffer, pH 8.0, containing 0.1 M NaCl (22) . The average yield of CY inactivator by this method was in the range of 10-15% (plasma concentration being 18 mg/ 100 ml). The final product formed a single precipitin arc in the a2 region with rabbit anti-human serum antibody by immunoelectrophoresis (23) . SDS-acrylamide (5% gel) electrophoretic analysis of the CY inactivator preparation demon- 2 Abbreviations used in this paper: DTT, dithiothreitol; PAS, periodic acid-Schiff; SBTI, soybean trypsin inhibitor; SDS, sodium dodecyl sulfate. product possessed less than 1% spontaneous plasmin activity as assayed by a standard caseinolytic assay (27) (30, 31) in 30 min at 370C in a total volume of 0.6 ml was first determined. In various experiments this averaged 10-30 ng of Cls to inactivate C2 and 1-10 ng of Cls to inactivate C4. The concentration of Cls selected from these studies was then incubated with 60-300 ng of C1 inactivator or enzyme-treated CY inactivator for 5 min at 370C in a total volume of 0.4 ml before addition of 0.2 ml of C2 or C4. After 30 min at 370C, the remaining active C2 or C4 was assayed. In all experiments inactivation of C2 and C4 was assessed by measurement of residual hemolytic activity (32) .
The plasmin-inhibiting activity of Ci inactivator was assessed in a fibrinolytic assay (33) . Varying concentrations of C1 inactivator were preincubated (5 min, 371C) with urokinase-activated plasmin, and the residual fibrinolytic activity was determined. legends. The molar ratios of enzyme to inhibitor were calculated by using the following molecular weights: trypsin, 23,300 (37); plasmin, 73,500; and Cis, 72,000 as determined for the preparations used in the present study. The concentration of trypsin used was determined by active site titration with p-nitrophenyl p'-guanidinobenzoate HCl as described by Chase and Shaw (38) . Portions of the incubation mixtures were added to an equal volume of a solution containing 10 M urea, 2% SDS, and if disulfide bond reduction was desired, DTT (14 mM final concentration) was employed. After incubation for 45 min at 37°C, the samples were analyzed by electrophoresis in polyacrylamide gels (5%) containing SDS (39) . The gels were stained with Coomassie Brilliant Blue. Selected gels were stained with periodic-acid Schiff (PAS) reagent (40) . Densitometric scans of gels were carried out in a Gilford Model 240 spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio), equipped with a linear transport device. The molecular weight of C1 inactivator and its reaction products was determined by SDS-acrylamide gel electrophoresis as described (37, 39) . The proteins used for molecular weight markers were reduced before electrophoresis. They included phosphorylase A, 94,000 (39) from Sigma Chemical Co.; ovalbumin, 43,000 (39) from Pharmacia Fine Chemicals, Inc.; chymotrypsin, 25,000 (39) from Calbiochem; a2-macroglobulin subunit chain, 185,000 and its trypsin-induced proteolytic derivative, 85,000 were prepared as described (8) .
Human fibrinogen (A a-chain, 70,900; B ,3-chain, 60,400; and -y-chain, 49,400) (41) Both bands stained heavily with PAS and the concentration of PAS-staining material in each band relative to duplicate SDS-acrylamide gels stained with either amido black or Coomassie blue stain was constant. This indicated that band II possessed PAS-reactive material in a concentration similar to that found for the major C1 inactivator band (I).
In the C1 inactivator preparation shown in Fig. 1 , the concentration of band II relative to band I was approximately 15% as assessed by densitometric scans of the acrylamide gels. The following studies demonstrated the immunological identity of bands I and II. After electrophoresis of C1 inactivator in SDS-acrylamide gels, the gels were cut longitudinally and embedded in an agarose plate and analyzed by immunodiffusion against rabbit antiserum to C1 inactivator placed in a parallel slot in the agarose (Fig. 1) . Alternatively, the sectioned gels were electrophoresed at right angles to their longitudinal axes into agarose containing the antibody (43) (Fig. 1 ). Immunodiffusion revealed two arcs which joined without spur formation in positions corresponding to bands I and II of the Cl inactivator preparation. On crossed electrophoresis larger and smaller peaks of precipitation corresponding to bands I and II, respectively, were apparent (Fig. 1) .
These studies document the existence of two immunologically identical forms of C1 inactivator differing from each other by approximately 9,000 daltons in molecular weight. Both forms apparently represent a single polypeptide chain and both contain large amounts of carbohydrate. Functional studies of bands I and II are presented below.
Studies on the interaction between C1 inactivator and Cis (Fig. 2) . Mixtures of C1 inactivator and Cis were prepared and subjected to electrophoresis in SDSacrylamide gels (Fig. 2) . In the absence of reducing agents, two new slower moving bands (complex I and II) were apparent (Fig. 2, gel (Fig. 2, gels b and c) . These studies indicated that both bands of the inhibitor preparation formed a 1: 1 molar complex with Cis.
Major alterations in the band pattern of Cls-C1 inactivator mixtures were apparent on reduction of the sample before electrophoresis (Fig. 2, gel (Fig. 4) , and were tested as well for their ability to inhibit Cis-mediated inactivation of C4 as described in Methods.
served on SDS-acrylamide gel analysis, in the absence of reducing agents, of equimolar mixtures of C1 inactivator and plasmin (Fig. 3, gel c) . Thus, plasmin also formed a 1: 1 molar complex with the C1 inactivator. Functional studies of the fibrinolytic inhibitory activity of C1 inactivator confirmed this stoichiometric relationship. However, in contrast to the predominance of band I in the Cis-C1 inactivator complex (cf Fig. 2 , gel c), with plasmin the band II complex was predominant. These findings suggested that plasmin had produced a lower molecular weight derivative of the C1 inactivator molecule that formed a complex with the enzyme.3 Residual, unincorporated C1 inactivator was also converted to a pattern in which material occupying the band II position represented the major proportion of the C1 inactivator preparation (Fig. 3,  gel c) .
Results analogous to those obtained with Cls and C1 inactivator (Fig. 2 , gel e) were observed after reduction of the plasmin-CI inactivator mixtures (Fig. 3, gel e) .
As compared to the unreduced sample, high molecular weight complex I and II were absent and two new bands III and IV, with molecular weights of 125,000 and 115,000 daltons were observed. Since the heavy chain but not light chain of plasmin appeared after re- ' As is apparent from inspection of Fig. 3 , gel a, the plasmin preparation contained two bands of molecular weights 75,000 and 72,000 daltons, and the loss of these bands in the mixture of plasmin and inhibitor (Fig. 3, gel c) indicated that both of these molecular weight forms of plasmin were bound in the enzyme-inhibitor complex. The 9,000-dalton difference between bands I and II of the plasmin-inhibitor complex ruled out the possibility that these bands were due solely to the binding of the two forms of plasmin. duction (Fig. 3, gel e) , bands III and IV apparently represented the formation of complexes between the light chain of plasmin and band I of the CI inactivator preparation and the plasmin-induced derivative of the C! inactivator preparation.
Incubation of increasing molar ratios of plasmin (0.5, 1.0, 2.0, and 3.0) relative to C! inactivator produced proportional increases in complex band II and of residual uncomplexed material occupying the C1 inactivator band II positions. This was coupled with a parallel loss of both band I of the complex and the residual band I of the CI inactivator (Fig. 4, gels a-e) .
These findings provided further support for the conclusion that plasmin had formed a complex with the product derived from its cleavage of the C! inactivator molecule.
Portions from a plasmin-Ci inactivator incubation mixture (0.5 molar ratio) were examined sequentially to determine whether a time-dependent conversion of complex I (consisting of plasmin and C! inactivator band I) to complex II might occur. No such conversion occurred as the reaction was found to be complete at the time of the first sample (1 min), and the SDSacrylamide gel pattern remained unchanged and similar to that shown in Fig. 4 , gel b, during an additional 3-h incubation period at 370C.
An additional feature of the plasmin-C! inactivator interaction was apparent at plasmin concentrations greater than equimolar (Fig. 4, gels d and e) . Even in the presence of a molar ratio of 3, there was a substantial amount of material in the position of the Cl inactivator band II, indicating that a C! inactivator derivative had been produced by the action of plasmin which did not form a complex with this enzyme. Thus, it can be inferred that plasmin cleaved the C! inhibitor molecule (band I) yielding at least two derivatives with similar molecular weights. One of these derivatives was functionally active as it formed a complex with plasmin, whereas the other appeared to be functionally inactive.
Studies of the interaction between plasmin, C7 inactivator, and Cfs (Fig. 5) . The residual Cls binding and inhibiting activity of C! inactivator in the plasmin incubation mixture was assessed in order to correlate the observed changes in the acrylamide gel pattern with functional alterations since inactivation of the inhibitor's esterolytic inhibiting activity by plasmin has previously been reported (44) . After the addition of SBTI to inhibit the residual proteolytic activity in the plasmin-Ci inactivator mixtures, concentrations of Cis equimolar to the Cl inactivator were added. Acrylamide gel electrophoretic analyses of these mixtures (not shown) demonstrated that the addition of Cis was associated with a loss of material from C1 inactivator bands I and II of the samples of C1 inactivator previously treated with 0.5 and 1.0 molar ratios of plasmin. Studies of the interaction between trypsin, C7 inactivator, and Cls (Fig. 6) . In partial analogy to the results obtained with plasmin, increasing concentrations of trypsin caused a progressive depletion of C! inactivator band I with a proportional increase in a band which occupied the band II position of the inhibitor (Fig. 6,  gels a-d) . At In contrast, in the incubation mixtures containing plasmin-C! inactivator molar ratios of 2 and 3, no loss of material in the C! inactivator band II position was observed after the addition of Cls, nor was there an increase in band II position of the complex as compared to the samples without Cis. Therefore, the Cl inactivator band II derivative generated with large amounts of plasmin that failed to complex with plasmin was similarly unable to bind Cls.
The impairment of the functional ability of Ci inactivator after incubation with plasmin was also assessed (Fig. 5) . Plasmin-C1 inactivator mixtures after addition of excess SBTI were incubated with Cis, and residual Cls function was tested by examining the ability of the mixture to inactivate C4 ( Equal volumes of increasing concentrations of trypsin (16, 32 , and 320,ug/ml; gels b-d) were incubated with C1 inactivator (1.5 mg/ml) for 10 min at 37°C. After the addition of an equal volume of SBTI (2.0 mg/ml), Cls (1 mg/ml) was added and incubated an additional 10 30 min at 37°C and neutralized with 1/6 N NaOH. The Lintreated (C) and acid-treated (H+) inhibitors (1.5 mg/ml) were then incubated with Cis (0.9 mg/ml), plasmin (1.1 mg/ml), or trypsin (320 jAg/ml) for 10 min at 37°C. The mixtures were analyzed after the addition of an SDS-urea solution. The native CY inactivator with buffer, plasmin, or trypsin was applied to gels a, c, and e; and the denatured inhibitor with buffer or the enzymes to gels b, d, and f. " In I I I" indicates the 86,000 dalton CY inactivator trypsin derivative. "In IV" and "In V" indicate the new C1 inactivator proteolytic derivatives resulting from the action of plasmin (IV) and trypsin (IV, V) on the acid-treated inhibitor (gels d and f). The gels were overloaded with sample in order to render the bands in gel f visible at comparable protein concentrations.
band I or trypsin-generated band II or III was observed under any of the concentrations examined. 4 Further studies showed that the carbohydrate portion of the C1 inactivator molecule was retained in the trypsin derivative bands II and III as well as in the plasmin-derived band II material as documented by densitometric scans of PAS-stained SDS-acrylamide gels.
4No complex formation between plasmin or trypsin and SBTI was apparent from inspection of SDS-acrylamide gels (Fig. 4, gel e; Figs. 6 and 7, gel d) . This suggests that the bonds involved in their interactions are noncovalent as they are disrupted at neutral pH by the denaturing agents used for sample preparations (SDS and urea).
The trypsin-treated C! inactivator preparations were also examined for their ability to form a complex with Cis. Complex formation was partially inhibited with molar ratios as low as 0.025 (not shown) and totally inhibited at a molar ratio of 0.1 (Fig. 7, gels a-d) . Trypsin-generated C1 inactivator band II was completely unable to form a complex with Cis. Thus, it resembled the inactive Cl inactivator band II material generated by plasmin. Functional studies of ability of trypsin-treated CI inactivator to inhibit Cls-mediated destruction of C2 and C4 demonstrated that loss of functional inhibitor activity paralleled the loss of ability of C! inactivator to form a complex with Cls as analyzed by SDS-acrylamide gel electrophoresis.
Effect of acid treatment of Cl inactivator on its interaction with Cls, plasmin, and trypsin (Fig. 8) . Acidtreated C! inactivator has been previously reported to be functionally inactive (10) . Acid-treated CI inactivator was examined for the ability to complex with plasmin and Cls. After acidification to pH 2.0 for 30 min at 370C followed by neutralization, C! inactivator was incubated with the various enzymes. Acid treatment produced no evident alteration in the apparent molecular weight or proportion of bands I and II as assessed by SDS-polyacrylamide gel electrophoresis. The acidified inhibitor, however, was unable to form a complex with Cls or plasmin (Fig. 8, gels a-d) . Although Cls did not alter the acid-treated C! inactivator (as compared to gels containing each component alone) both plasmin and trypsin degraded C! inactivator (Fig. 8, gels d and f) , and produced a new plasmin derivative (IV) with an apparent molecular weight of 58,000 daltons, and the two new trypsin derivatives (IV and V) with apparent molecular weights of 58,000 and 42,500 daltons. The relative faintness of the bands which were apparent after the reaction of trypsin with acid-treated inhibitor (Fig. 8, gel f) suggested that a considerable portion of the inhibitor molecule had been hydrolyzed to produce lower molecular weight products not identifiable by the method used. Studies of radiolabeled C7 inactivator-enzyme interactions were undertaken in an attempt to identify the low molecular weight products cleaved from the inhibitor by plasmin and trypsin. The theoretical molecular weight of these products would represent, for example, the difference between plasmin-derived band II and native band I, or approximately 9,000 daltons. Incubation mixtures of '251-labeled Cl inactivator and unlabled Cls, plasmin, or trypsin were analyzed by SDS-acrylamide gel electrophoresis. After the electrophoretic procedure, the gels were sliced and the segments counted or the whole gel was dried and autoradiography performed (45) . These studies, although confirming that the inhibitor was incorporated into higher molecular weight complexes, revealed no evidence for radioactive fragments having molecular weights of 9,000 daltons or lower.
DISCUSSION
Acrylamide gel electrophoresis in the presence of SDS has made it possible to define more precisely the structure of Cl inactivator and the nature of the interactions which occur between C! inactivator and several of the plasma enzymes which it inhibits. These reactions are outlined in Fig. 9 , and depending on the enzyme, were characterized by the formation of stable stoichiometric complexes as well as by the production of both active and inactive inhibitor derivatives. The C! inactivator formed a complex with both Cls and plasmin which remained intact in the presence of the denaturing agents urea and SDS. The molecular weight of the complex reflected the sum of the individual chains providing direct evidence for a 1:1 molar binding ratio between the inhibitor and these enzymes, a finding extending functional (12) and ultracentrifugal studies (46) which indicated a stoichiometric relationship between Cis and its inhibitor. Electrophoretic analysis on SDS-acrylamide gels of mixtures containing equimolar concentrations of enzyme and inhibitor, after reductive cleavage of disulfide bonds by DTT, showed that the heavy chain of the enzyme had separated from the complex, however, no band occupying the position of the light chain could be identified. Further, a new band had appeared which possessed a molecular weight equal to the sum of the weights of the inhibitor and the light chain of the enzyme. Thus, the binding site(s) of these enzymes for C! inactivator was found to be located on the subunit chain which contained the active site of Cis (47) and plasmin (48) . Functional studies of the proteolytic activity of these enzymes after incubation with C! inactivator confirmed that complex formation, as documented by electrophoretic analysis, was associated with inhibition of enzymic activity.
In addition to complex formation, the interaction of C! inactivator with plasmin resulted in proteolytic degradation of the inhibitor (as outlined in the schema shown in Fig. 9 (Fig. 5 ) paralleled the development of the I The 96,000-dalton derivative produced by interaction of plasmin with Cl inactivator and which forms a complex with plasmin has been designated band "Ila" for the "active" product. The derivative with similar mobility in SDSacrylamide gels which was produced by plasmin was designated band "IIi" for the "inactive" product. Similarly, the trypsin-induced C! inactivator derivative with an apparent molecular weight of 86,000 which was inactive in complex formation was designated band "lii."
plasmin-inhibitor complex as well as of the IIi derivative. to inhibit its activity, indicating that the loss of a 9,000-dalton portion of the native molecule did not affect its inhibitory function. In contrast, the trypsinand plasmin-produced IIi derivative possessed an apparent molecular weight similar to that of the Ila product, but it had lost its inhibitory activity. It is likely that trypsin as well as the higher concentrations of plasmin used had attacked an additional region in the inhibitor molecule releasing a small peptide, and producing a molecular weight change in the parent chain too small to be appreciated by SDS-acrylamide gel electrophoresis. Although it is possible that the released peptide contained a critical binding site for the enzyme, it is more likely that the additional cleavage altered the conformation of the molecule and thereby destroyed its function. This concept is supported by data which demonstrated that acid treatment of C1 inactivator, a procedure which altered its native conformation, rendered it functionally inactive (Fig. 8) .
The role of peptide bond cleavage in the interaction between the proteolytic enzymes and their naturally occurring inhibitors has not been established. From his studies of the trypsin-SBTI reaction, as well as of other inhibitors of plant origin, Laskowski (49) has concluded that proteases hydrolyze peptide bonds in their inhibitors as a requirement for complex formation and enzymic inhibition. In the case of the trypsin-SBTI reaction, he postulated that cleavage of the inhibitor by trypsin resulted in the formation of a covalent acyl enzyme intermediate between the enzyme and the inhibitor. In contrast, Feeney (50) suggested that the strength of binding between enzyme and its inhibitor is secondary to the summation of many hydrophobic and electrostatic interactions. In this theory, proteolysis of the inhibitor is a coincidental event. Data supporting this assumption has been provided by Ako, Foster, and Ryan (51) who demonstrated complex formation between an enzymically inactive trypsin derivative and SBTI with an energy of inhibitor binding similar to that established for active trypsin.
Additional evidence suggesting that complex formation between an enzyme and its inhibitor, active site inhibition, and inhibitor hydrolysis may be unrelated events was provided by studies that demonstrated that formation of a complex between a2-macroglobulin and trypsin, thrombin, plasmin, and plasma kallikrein was accompanied by limited proteolysis of the a2-macroglobulin molecule (8) . The active site of the enzyme in the complex, however, retained the capacity to hydrolyze synthetic amino acid esters, and in the case of the a2-macroglobulin-plasmin complex, retained fibrinogenolytic activity (52) . In the present investigation, derivatives were not identified after the interaction of Cis and C1 inactivator. Furthermore, aciddenatured C1 inactivator resisted proteolytic attack by this enzyme suggesting that C1 inactivator was not a substrate for Cis and consequently that cleavage was not a requirement for complex formation.
In summary, in this study a variety of molecular interactions occurring between Cls, plasmin, trypsin, and C1 inactivator, a circulating inhibitor of components of the complement, coagulation, fibrinolytic, and kallikrein enzyme systems have been examined. A spectrum of reactions was identified and included the formation of stable complexes, as well as of proteolytic cleavage of the inhibitor yielding functionally active lower molecular weight inhibitor derivatives. In addition, proteolysis also resulted in the production of inactive inhibitor derivatives. These interactions may serve as a model for the study of mechanisms of action of the other plasma enzyme inhibitors. 
